Companies / Inovio Pharmaceuticals, Inc.
Inovio Pharmaceuticals, Inc.
Financials · FY2025
Ownership
103.4M shares outstanding · as of Aug 10, 2026
Ownership
| Insiders | 0.32% | 330,328 |
| 10%+ / strategic | 16.11% | 16,655,193 |
| Institutions | 17.88% | 18,486,562 |
| Public float | 65.69% | 67,925,435 |
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 11
View all →| Insider | % of shares | Shares |
|---|---|---|
Shea Jacqueline ElizabethCEOChief Executive Officer · Director | 0.11% | 111,021 |
Weiner David B.Director | 0.08% | 87,592 |
Humeau LaurentChief Scientific Officer | 0.05% | 46,823 |
Kies PeterCFO | 0.04% | 42,854 |
Sumner Michael JohnChief Medical Officer | 0.04% | 42,038 |
Benito Simon XDirector | — | — |
Dansey Roger DDirector | — | — |
Miller Ann CalbyDirector | — | — |
Shepard JayDirector | — | — |
Yarno Wendy LDirector | — | — |
Institutional holders 101
View all →| Holder | Value | % of shares |
|---|---|---|
| $17.13M | 9.52% | |
| $5.77M | 3.20% | |
| $5.77M | 3.21% | |
| $4.21M | 2.34% | |
| $3.85M | 2.14% | |
| $2.58M | 1.44% | |
| $2.45M | 1.36% | |
| $1.40M | 0.78% | |
| $1.40M | 0.78% | |
| $1.12M | 0.62% |
Activity
InsidersInstitutions
What insiders are doing in this stock (Form 4).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Feb 26, 2026 | Shea Jacqueline Elizabeth CEO | Other | Common Stock | $24.4K | -14K -13.84% | 85,004 0.08% of shares | low |
| May 20, 2026 | Shea Jacqueline Elizabeth CEO | Other | Common Stock | $15.1K | -12K -9.98% | 111,021 0.11% of shares | low |
| Feb 26, 2026 | Shea Jacqueline Elizabeth CEO | Other | Common Stock | $14.4K | -8K -10.29% | 70,260 0.07% of shares | low |
| Feb 26, 2026 | Kies Peter Executive | Other | Common Stock | $11.3K | -6K -14.66% | 36,642 0.04% of shares | low |
| May 15, 2026 | Shea Jacqueline Elizabeth CEO | Other | Common Stock | $10.0K | -8K -7.51% | 95,031 0.09% of shares | low |
| Feb 26, 2026 | Sumner Michael John Executive | Other | Common Stock | $7.0K | -4K -11.34% | 30,507 0.03% of shares | low |
| May 20, 2026 | Kies Peter Executive | Other | Common Stock | $5.8K | -5K -9.86% | 42,854 0.04% of shares | low |
| Feb 26, 2026 | Humeau Laurent Executive | Other | Common Stock | $5.4K | -3K -7.07% | 39,900 0.04% of shares | low |
5%+ ownership events
Schedule 13D / 13G
| Filer | Stance | % of class |
|---|---|---|
| RA Capital Management, L.P. | Passive13G | — |
| Vanguard Group Inc | Passive13G/A | — |
| Alyeska Investment Group, L.P. | Passive13G/A | — |
| Fmr LLC | Passive13G/A | — |
| Adage Capital Management, L.P. | Passive13G/A | — |
| Highbridge Capital Management, LLC | Passive13G/A | — |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| INO | — | 45773H409 |